4pf7 - Revision history

OCA at 07:16, 27 September 2023

OCA — Wed, 27 Sep 2023 07:16:20 GMT

←Older revision		Revision as of 07:16, 27 September 2023
Line 4:		Line 4:
	== Structural highlights ==		== Structural highlights ==
	<table><tr><td colspan='2'>[[4pf7]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4PF7 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4PF7 FirstGlance]. <br>		<table><tr><td colspan='2'>[[4pf7]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4PF7 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4PF7 FirstGlance]. <br>
-	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=2QW:(2S)-2-AMINO-N-{(1S)-1-CYCLOHEXYL-2-[(4-METHYLPHENYL)AMINO]-2-OXOETHYL}-4-(METHYLSELANYL)BUTANAMIDE'>2QW</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr>	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 2.33Å</td></tr>
		+	<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=2QW:(2S)-2-AMINO-N-{(1S)-1-CYCLOHEXYL-2-[(4-METHYLPHENYL)AMINO]-2-OXOETHYL}-4-(METHYLSELANYL)BUTANAMIDE'>2QW</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr>
	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4pf7 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4pf7 OCA], [https://pdbe.org/4pf7 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4pf7 RCSB], [https://www.ebi.ac.uk/pdbsum/4pf7 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4pf7 ProSAT]</span></td></tr>		<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4pf7 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4pf7 OCA], [https://pdbe.org/4pf7 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4pf7 RCSB], [https://www.ebi.ac.uk/pdbsum/4pf7 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4pf7 ProSAT]</span></td></tr>
	</table>		</table>

OCA at 12:59, 1 February 2023

OCA — Wed, 01 Feb 2023 12:59:32 GMT

←Older revision		Revision as of 12:59, 1 February 2023
Line 3:		Line 3:
	<StructureSection load='4pf7' size='340' side='right'caption='[[4pf7]], [[Resolution\|resolution]] 2.33Å' scene=''>		<StructureSection load='4pf7' size='340' side='right'caption='[[4pf7]], [[Resolution\|resolution]] 2.33Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[4pf7]] is a 2 chain structure with sequence from [~~http~~://en.wikipedia.org/wiki/~~Human Human~~]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4PF7 OCA]. For a <b>guided tour on the structure components</b> use [~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=4PF7 FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[4pf7]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4PF7 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4PF7 FirstGlance]. <br>
-	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=2QW:(2S)-2-AMINO-N-{(1S)-1-CYCLOHEXYL-2-[(4-METHYLPHENYL)AMINO]-2-OXOETHYL}-4-(METHYLSELANYL)BUTANAMIDE'>2QW</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene~~></td></tr>~~	+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=2QW:(2S)-2-AMINO-N-{(1S)-1-CYCLOHEXYL-2-[(4-METHYLPHENYL)AMINO]-2-OXOETHYL}-4-(METHYLSELANYL)BUTANAMIDE'>2QW</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr>
-	~~<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4pf9\|4pf9]], [[4pfc\|4pfc]]</td></tr>~~	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4pf7 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4pf7 OCA], [https://pdbe.org/4pf7 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4pf7 RCSB], [https://www.ebi.ac.uk/pdbsum/4pf7 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4pf7 ProSAT]</span></td></tr>
-	~~<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">IDE ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>~~	+
-	<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Insulysin Insulysin], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.24.56 3.4.24.56] </span></td></tr>	+
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=4pf7 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4pf7 OCA], [~~http~~://pdbe.org/4pf7 PDBe], [~~http~~://www.rcsb.org/pdb/explore.do?structureId=4pf7 RCSB], [~~http~~://www.ebi.ac.uk/pdbsum/4pf7 PDBsum], [~~http~~://prosat.h-its.org/prosat/prosatexe?pdbcode=4pf7 ProSAT]</span></td></tr>	+
	</table>		</table>
	== Function ==		== Function ==
-	[~~[http~~://www.uniprot.org/uniprot/IDE_HUMAN IDE_HUMAN]] Plays a role in the cellular breakdown of insulin, IAPP, glucagon, bradykinin, kallidin and other peptides, and thereby plays a role in intercellular peptide signaling. Degrades amyloid formed by APP and IAPP. May play a role in the degradation and clearance of naturally secreted amyloid beta-protein by neurons and microglia.<ref>PMID:10684867</ref> <ref>PMID:17613531</ref> <ref>PMID:18986166</ref>	+	[https://www.uniprot.org/uniprot/IDE_HUMAN IDE_HUMAN] Plays a role in the cellular breakdown of insulin, IAPP, glucagon, bradykinin, kallidin and other peptides, and thereby plays a role in intercellular peptide signaling. Degrades amyloid formed by APP and IAPP. May play a role in the degradation and clearance of naturally secreted amyloid beta-protein by neurons and microglia.<ref>PMID:10684867</ref> <ref>PMID:17613531</ref> <ref>PMID:18986166</ref>
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
	== Publication Abstract from PubMed ==		== Publication Abstract from PubMed ==
Line 23:		Line 20:

	==See Also==		==See Also==
-	*[[Insulin-~~Degrading Enzyme~~\|Insulin-~~Degrading Enzyme~~]]	+	*[[Insulin-degrading enzyme 3D structures\|Insulin-degrading enzyme 3D structures]]
	== References ==		== References ==
	<references/>		<references/>
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
-	[[Category: ~~Human]]~~	+	[[Category: Homo sapiens]]
-	~~[[Category: Insulysin~~]]	+
	[[Category: Large Structures]]		[[Category: Large Structures]]
-	[[Category: Guo, S]]	+	[[Category: Guo S]]
-	[[Category: Wang, Y]]	+	[[Category: Wang Y]]
-	~~[[Category: Hydrolase-hydrolase inhibitor complex~~]]	+

OCA at 07:56, 17 April 2019

OCA — Wed, 17 Apr 2019 07:56:33 GMT

←Older revision		Revision as of 07:56, 17 April 2019
Line 1:		Line 1:
		+
	==Crystal structure of insulin degrading enzyme complexed with inhibitor==		==Crystal structure of insulin degrading enzyme complexed with inhibitor==
-	<StructureSection load='4pf7' size='340' side='right' caption='[[4pf7]], [[Resolution\|resolution]] 2.33Å' scene=''>	+	<StructureSection load='4pf7' size='340' side='right'caption='[[4pf7]], [[Resolution\|resolution]] 2.33Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[4pf7]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4PF7 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4PF7 FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[4pf7]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4PF7 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4PF7 FirstGlance]. <br>
	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=2QW:(2S)-2-AMINO-N-{(1S)-1-CYCLOHEXYL-2-[(4-METHYLPHENYL)AMINO]-2-OXOETHYL}-4-(METHYLSELANYL)BUTANAMIDE'>2QW</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr>		</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=2QW:(2S)-2-AMINO-N-{(1S)-1-CYCLOHEXYL-2-[(4-METHYLPHENYL)AMINO]-2-OXOETHYL}-4-(METHYLSELANYL)BUTANAMIDE'>2QW</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr>
	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4pf9\|4pf9]], [[4pfc\|4pfc]]</td></tr>		<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4pf9\|4pf9]], [[4pfc\|4pfc]]</td></tr>
		+	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">IDE ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>
	<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Insulysin Insulysin], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.24.56 3.4.24.56] </span></td></tr>		<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Insulysin Insulysin], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.24.56 3.4.24.56] </span></td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4pf7 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4pf7 OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4pf7 RCSB], [http://www.ebi.ac.uk/pdbsum/4pf7 PDBsum]</span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4pf7 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4pf7 OCA], [http://pdbe.org/4pf7 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4pf7 RCSB], [http://www.ebi.ac.uk/pdbsum/4pf7 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4pf7 ProSAT]</span></td></tr>
	</table>		</table>
	== Function ==		== Function ==
Line 18:		Line 20:
	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>		From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
	</div>		</div>
		+	<div class="pdbe-citations 4pf7" style="background-color:#fffaf0;"></div>
		+
		+	==See Also==
		+	*[[Insulin-Degrading Enzyme\|Insulin-Degrading Enzyme]]
	== References ==		== References ==
	<references/>		<references/>
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: Human]]
	[[Category: Insulysin]]		[[Category: Insulysin]]
		+	[[Category: Large Structures]]
	[[Category: Guo, S]]		[[Category: Guo, S]]
	[[Category: Wang, Y]]		[[Category: Wang, Y]]
	[[Category: Hydrolase-hydrolase inhibitor complex]]		[[Category: Hydrolase-hydrolase inhibitor complex]]

OCA at 08:20, 8 July 2015

OCA — Wed, 08 Jul 2015 08:20:00 GMT

←Older revision		Revision as of 08:20, 8 July 2015
Line 10:		Line 10:
	== Function ==		== Function ==
	[[http://www.uniprot.org/uniprot/IDE_HUMAN IDE_HUMAN]] Plays a role in the cellular breakdown of insulin, IAPP, glucagon, bradykinin, kallidin and other peptides, and thereby plays a role in intercellular peptide signaling. Degrades amyloid formed by APP and IAPP. May play a role in the degradation and clearance of naturally secreted amyloid beta-protein by neurons and microglia.<ref>PMID:10684867</ref> <ref>PMID:17613531</ref> <ref>PMID:18986166</ref>		[[http://www.uniprot.org/uniprot/IDE_HUMAN IDE_HUMAN]] Plays a role in the cellular breakdown of insulin, IAPP, glucagon, bradykinin, kallidin and other peptides, and thereby plays a role in intercellular peptide signaling. Degrades amyloid formed by APP and IAPP. May play a role in the degradation and clearance of naturally secreted amyloid beta-protein by neurons and microglia.<ref>PMID:10684867</ref> <ref>PMID:17613531</ref> <ref>PMID:18986166</ref>
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	Insulin-degrading enzyme (IDE, insulysin) is the best characterized catabolic enzyme implicated in proteolysis of insulin. Recently, a peptide inhibitor of IDE has been shown to affect levels of insulin, amylin, and glucagon in vivo. However, IDE-/- mice display variable phenotypes relating to fasting plasma insulin levels, glucose tolerance, and insulin sensitivity depending on the cohort and age of animals. Here, we interrogated the importance of IDE-mediated catabolism on insulin clearance in vivo. Using structure-based design, we linked two newly identified ligands binding at unique IDE exosites together to construct a potent series of novel inhibitors. These compounds do not interact with the catalytic zinc of the protease. Since one of these inhibitors (NTE-1) was determined to have pharmacokinetic properties sufficient to sustain plasma levels >50x its IDE IC50, studies in rodents were conducted. In oral glucose tolerance tests with diet-induced obese (DIO) mice, NTE-1 treatment improved glucose clearance. Yet, in insulin tolerance tests and euglycemic clamp experiments, NTE-1 did not improve insulin action or increase plasma insulin levels. Importantly, IDE inhibition with NTE-1 did result in elevated plasma amylin levels, suggesting the in vivo role of IDE action on amylin may be more significant than an effect on insulin. Further, using the inhibitors described in this report, we demonstrate that in HEK cells IDE has little impact on insulin clearance. In total, evidence from our studies supports a minimal role for IDE in insulin clearance in vivo and suggest IDE may be more important in helping regulate amylin clearance in vivo.
		+
		+	Dual Exosite-binding Inhibitors of Insulin-degrading Enzyme Challenge Its Role as the Primary Mediator of Insulin Clearance in vivo.,Durham TB, Toth JL, Klimkowski VJ, Cao JX, Siesky AM, Alexander-Chacko J, Wu GY, Dixon JT, McGee JE, Wang Y, Guo SY, Cavitt RN, Schindler J, Thibodeaux SJ, Calvert NA, Coghlan MJ, Sindelar DK, Christe M, Kiselyov VV, Michael MD, Sloop KW J Biol Chem. 2015 Jun 17. pii: jbc.M115.638205. PMID:26085101<ref>PMID:26085101</ref>
		+
		+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
		+	</div>
	== References ==		== References ==
	<references/>		<references/>

OCA at 15:20, 17 June 2015

OCA — Wed, 17 Jun 2015 15:20:33 GMT

←Older revision		Revision as of 15:20, 17 June 2015
Line 1:		Line 1:
-	'''~~Unreleased structure~~'''	+	==Crystal structure of insulin degrading enzyme complexed with inhibitor==
-		+	<StructureSection load='4pf7' size='340' side='right' caption='[[4pf7]], [[Resolution\|resolution]] 2.33Å' scene=''>
-	~~The entry~~ 4pf7 is ~~ON HOLD until Paper Publication~~	+	== Structural highlights ==
-		+	<table><tr><td colspan='2'>[[4pf7]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4PF7 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4PF7 FirstGlance]. <br>
-	~~Authors~~: ~~Wang~~, Y., ~~Guo~~, S.	+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=2QW:(2S)-2-AMINO-N-{(1S)-1-CYCLOHEXYL-2-[(4-METHYLPHENYL)AMINO]-2-OXOETHYL}-4-(METHYLSELANYL)BUTANAMIDE'>2QW</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr>
-		+	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4pf9\|4pf9]], [[4pfc\|4pfc]]</td></tr>
-	~~Description~~:	+	<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Insulysin Insulysin], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.24.56 3.4.24.56] </span></td></tr>
-	[[Category: ~~Unreleased Structures~~]]	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4pf7 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4pf7 OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4pf7 RCSB], [http://www.ebi.ac.uk/pdbsum/4pf7 PDBsum]</span></td></tr>
		+	</table>
		+	== Function ==
		+	[[http://www.uniprot.org/uniprot/IDE_HUMAN IDE_HUMAN]] Plays a role in the cellular breakdown of insulin, IAPP, glucagon, bradykinin, kallidin and other peptides, and thereby plays a role in intercellular peptide signaling. Degrades amyloid formed by APP and IAPP. May play a role in the degradation and clearance of naturally secreted amyloid beta-protein by neurons and microglia.<ref>PMID:10684867</ref> <ref>PMID:17613531</ref> <ref>PMID:18986166</ref>
		+	== References ==
		+	<references/>
		+	__TOC__
		+	</StructureSection>
		+	[[Category: Insulysin]]
	[[Category: Guo, S]]		[[Category: Guo, S]]
	[[Category: Wang, Y]]		[[Category: Wang, Y]]
		+	[[Category: Hydrolase-hydrolase inhibitor complex]]

OCA at 14:59, 24 December 2014

OCA — Wed, 24 Dec 2014 14:59:47 GMT

←Older revision		Revision as of 14:59, 24 December 2014
Line 5:		Line 5:
	Authors: Wang, Y., Guo, S.		Authors: Wang, Y., Guo, S.

-	Description:	+	Description:
		+	[[Category: Unreleased Structures]]
		+	[[Category: Guo, S]]
		+	[[Category: Wang, Y]]

OCA at 08:09, 28 May 2014

OCA — Wed, 28 May 2014 08:09:38 GMT

←Older revision		Revision as of 08:09, 28 May 2014
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 4pf7 is ON HOLD	+	The entry 4pf7 is ON HOLD until Paper Publication

	Authors: Wang, Y., Guo, S.		Authors: Wang, Y., Guo, S.

	Description:		Description:

OCA: Protected "4pf7" [edit=sysop:move=sysop]

OCA — Wed, 07 May 2014 07:43:59 GMT

Protected "4pf7" [edit=sysop:move=sysop]

←Older revision

Revision as of 07:43, 7 May 2014

OCA: New page: '''Unreleased structure''' The entry 4pf7 is ON HOLD Authors: Wang, Y., Guo, S. Description:

OCA — Wed, 07 May 2014 07:43:58 GMT

New page: '''Unreleased structure''' The entry 4pf7 is ON HOLD Authors: Wang, Y., Guo, S. Description:

New page

'''Unreleased structure'''

The entry 4pf7 is ON HOLD

Authors: Wang, Y., Guo, S.

Description: